Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers identify a gene responsible for spread of cancer in the body

03.03.2003


Researchers who are now at Georgetown University’s Lombardi Cancer Center have identified a gene that promotes metastases, the spread of cancer cells through the body. This new understanding of how cancer metastasizes, linking a gene product and migration of cancer cells, may lead to therapies to stop this spread. The results of the study are published in the May 2003 issue of the journal Molecular Biology of the Cell. An advance copy of the paper can be viewed after the embargo is lifted at http://www.molbiolcell.org/in_press.shtml



Richard G. Pestell, M.D., Ph.D. and his research team have been studying the cyclin D1 gene and the protein it produces for the past decade. Now they have found that by "knocking out" this gene, the migration of cells can be halted. The migration of cancer cells through the body is a major reason why cancer is deadly.

"Patients who do not survive their cancer, often don’t die from their primary cancer, usually they die from the spread of the disease through the body. If we can understand what causes the metastasis, then we can pinpoint new targets to block the spread of disease," said Dr. Pestell, director of the Lombardi Cancer Center, chairman of Georgetown’s Department of Oncology and Charlotte Gragnani professor of oncology. "Since cancerous -- but not normal epithelial cells -- migrate, therapy targeted to cell migration would be more selective. Killing only migrating cancer cells is thus less toxic, producing fewer side effects, than current chemotherapy which targets dividing cells of all types."


"We want to make the life journey a better one for people who have cancer," added Dr. Pestell, "and we at Lombardi are always trying to think of new approaches. Improving the quality of life for people with cancer is key. Slowing down the disease may change cancer from a fatal disease to one that can be lived with like diabetes."

The research was conducted at the Albert Einstein College of Medicine in New York where Dr. Pestell worked prior to joining the Lombardi Cancer Center at Georgetown.

This study was funded by the National Institutes of Health, the Susan G. Komen Breast Cancer Foundation and the Department of Defense. Co-authors of this study are Peter Neumeister, Fiona J. Pixley, Ying Xiong, Huafeng Xie, Koming Wu, Anthony Ashton, Michael Cammer, Amanda Chan, Marc Symons, and E. Richard Stanley.

In their Lombardi laboratories, Dr. Pestell and his colleagues are currently attempting to "fine tune" exactly how cell migration differs from cell proliferation so they can devise targeted drug therapy to stop the spread of cancer through the body.

They are also exploring a stealth anticancer weapon. They reported in the December 2002 issue of the journal Chemistry & Biology on initial research on a new modality called caging therapy that targets single malignant cells. Unlike taking a pill that goes to all cells in the body, caging therapy uses light beams in an extremely specific approach to eradicating individual cancer cells. These findings, as well as the developments described in the Molecular Biology of the Cell paper, hold the potential of significantly improving quality of life for cancer patients through the development of less toxic treatment options.


The Lombardi Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 40 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington DC area.

Editorial note: The Molecular Biology of the Cell paper includes an electron microscope video of migrating cancer cells. This can be viewed from a link available at http://www.molbiolcell.org/in_press.shtml after noon on February 28.

Cindy Fox Aisen | EurekAlert!
Further information:
http://www.molbiolcell.org/in_press.shtml

More articles from Health and Medicine:

nachricht Nanoparticles as a Solution against Antibiotic Resistance?
15.12.2017 | Friedrich-Schiller-Universität Jena

nachricht Plasmonic biosensors enable development of new easy-to-use health tests
14.12.2017 | Aalto University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-of-its-kind chemical oscillator offers new level of molecular control

DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.

Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Engineers program tiny robots to move, think like insects

15.12.2017 | Power and Electrical Engineering

One in 5 materials chemistry papers may be wrong, study suggests

15.12.2017 | Materials Sciences

New antbird species discovered in Peru by LSU ornithologists

15.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>